In development: Guidance, quality standards and advice
Showing 1 to 4 of 4
| Title | Type | Expected publication date |
|---|---|---|
| Ibrutinib for treating relapsed or refractory follicular lymphoma [ID1251] | Technology appraisal guidance | TBC |
| Ibrutinib with R-CHOP for untreated mantle cell lymphoma when an autologous stem cell transplant is suitable [ID6596] | Technology appraisal guidance | TBC |
| Venetoclax with ibrutinib for treating relapsed mantle cell lymphoma [ID3879] | Technology appraisal guidance | TBC |
| Waldenstrom's macroglobulinaemia - ibrutinib [ID884] | Technology appraisal guidance |